In targeted vascular drug delivery a wide range of length and time scales are required for describing the physics of hydrodynamic and microscopic molecular interactions mediating nanocarrier (NC) motion in blood flow and endothelial cell binding. We can incorporate features of NC design and optimization for clinical applications, including NC dimension, concentration, density of targeting molecules and characteristics of linkers used to attach targeting molecules into computational models bridging the relevant multiple scales. Simulations can limit the need for large scale n vivo and in vitro experimentation. We hypothesize that development of computational techniques required to bridge relevant molecular dynamics, mesoscale binding interactions and hydrodynamics governing NC transport and cellular adhesion is essential to establishing multiscale computation as a means of optimizing endothelial-targeted, NC-based drug delivery. While our main associated therapeutic goal is to optimize endothelial delivery of antioxidant and anti-inflammatory agents for alleviation of acute pulmonary inflammation and oxidative stress in conditions such as acute lung injury (ALI/ARDS) and ischemia-reperfusion (I/R) in which pulmonary endothelial ICAM-1 surface density increases, the modeling is adaptable for vascular endothelial targeting n any organ system. Our bridged modeling will be validated through synergistic cell cultue and animal experiments of binding of selectively developed NCs. This will be studied va three specific aims:
Aim 1 : Implement multiscale modeling of hydrodynamic and microscopic interactions of NC motion in blood flow. We will develop bridging techniques to account rigorously for multiple length and time scales to treat multivalent adhesion interactions and hydrodynamic and near-wall effects of glycocalyx flow and resistance.
Aim 2 : Develop a stochastic multiscale adhesion model of NC binding to endothelial cells mediated by multivalent antigen-antibody interactions. The model will bridge multiple degrees of freedom at different length scales to incorporate: (i) NC translation and rotation as well as antigen/antibody translation, orientation and flexure~ (ii) effect of tethers mediating conformational accessibility and binding~ (iii) effects of flow and resistance due to glycocalyx captured in Aim 1~ and (iv) a bridging technique developed to integrate molecular models of binding interactions with the mesoscale NC model. Computational modeling approaches will be tuned using sensitivity analysis.
Aim 3 : Experimentally quantify NC targeting kinetics in vitro and in vivo using NCs incorporating a range of tethered single-chain variable fragments (scFv) and alternative surface molecules for anti-ICAM activity, using different length PEG tethers on different size NCs at varying surface density. Validation of numerical simulations will be based on direct comparison of predictions with experimental measures of cell binding. Our modeling and experimental approaches will enable us to develop and bridge multiscale techniques for clinical translation.
Targeted vascular drug delivery is inherently a multiscale problem with a wide range of length scales and time scales being important to the physics and mechanics of nanocarrier motion in blood flow and endothelial cell binding. We are developing computational methods to bridge the multiple scales that must be incorporated into modeling schemes for them to optimize targeted vascular drug delivery. Our model will be validated through representative cell culture and animal experiments of molecularly targeted nanocarrier delivery to cells. This work will enable high throughput computational predictions to be performed to optimize nanocarrier design for treatment of lung diseases as well as many diseases in other human organs.
|Vitoshkin, Helena; Yu, Hsiu-Yu; Eckmann, David M et al. (2016) Nanoparticle stochastic motion in the inertial regime and hydrodynamic interactions close to a cylindrical wall. Phys Rev Fluids 1:|
|Clancy, Colleen E; An, Gary; Cannon, William R et al. (2016) Multiscale Modeling in the Clinic: Drug Design and Development. Ann Biomed Eng 44:2591-610|
|Myerson, Jacob W; Anselmo, Aaron C; Liu, Yaling et al. (2016) Non-affinity factors modulating vascular targeting of nano- and microcarriers. Adv Drug Deliv Rev 99:97-112|
|Ramakrishnan, N; Tourdot, Richard W; Radhakrishnan, Ravi (2016) Thermodynamic free energy methods to investigate shape transitions in bilayer membranes. Int J Adv Eng Sci Appl Math 8:88-100|
|Ramakrishnan, N; Tourdot, Richard W; Eckmann, David M et al. (2016) Biophysically inspired model for functionalized nanocarrier adhesion to cell surface: roles of protein expression and mechanical factors. R Soc Open Sci 3:160260|
|Zhang, Yanhang; Barocas, Victor H; Berceli, Scott A et al. (2016) Multi-scale Modeling of the Cardiovascular System: Disease Development, Progression, and Clinical Intervention. Ann Biomed Eng 44:2642-60|
|Han, Jingyan; Shuvaev, Vladimir V; Davies, Peter F et al. (2015) Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1. J Control Release 210:39-47|
|Slochower, David R; Wang, Yu-Hsiu; Radhakrishnan, Ravi et al. (2015) Physical chemistry and membrane properties of two phosphatidylinositol bisphosphate isomers. Phys Chem Chem Phys 17:12608-15|
|Ramakrishnan, N; Radhakrishnan, Ravi (2015) Phenomenology based multiscale models as tools to understand cell membrane and organelle morphologies. Adv Planar Lipid Bilayers Liposomes 22:129-175|
|Yu, Hsiu-Yu; Eckmann, David M; Ayyaswamy, Portonovo S et al. (2015) Composite generalized Langevin equation for Brownian motion in different hydrodynamic and adhesion regimes. Phys Rev E Stat Nonlin Soft Matter Phys 91:052303|
Showing the most recent 10 out of 18 publications